CVS Health reports $106.1 billion second-quarter revenue

• The single biggest result was CVS Health reporting $106.1 billion in second-quarter revenues and an adjusted EPS of $2.58.
• The company generated $10.6 billion in year-to-date operating cash flow and raised its full-year earnings guidance.
• Management stated they expect to continue their margin recovery plan while deploying agentic AI tools across operational centers.

CVS Health (NYSE:CVS) reported second-quarter revenues of $106.1 billion, representing a 7.3% increase driven by broad segment gains.

This financial outcome presents a strong contrast to the prior year, bolstered by the absence of historical litigation charges.

"As our businesses work together to deliver a technology-powered care engagement experience, we continue to deliver strong performance," said CVS Health Chairman and CEO David Joyner.

The corporation recorded $4.7 billion in operating income, with its health care benefits segment experiencing an 85.5% adjusted income increase.

Management raised full-year forecasts, and following the announcement, CVS Health's share price was down at $104.27.

The business generated $10.6 billion in operating cash flow while the health services division achieved 11.5% revenue growth.

The pharmacy division saw a 10.2% adjusted income rise, aided by Rite Aid acquisitions and new AI deployments.